Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease.

Martinho-Grueber, Maude; Kapoglou, Ioannis; Bravo, Francisco; Sarraj, Riad; Benz, Eileen; Restellini, Sophie; Biedermann, Luc; Rogler, Gerhard; Vavricka, Stephan R; Schoepfer, Alain; Maillard, Michel H; Michetti, Pierre; Brunner, Felix; Clair, Carole; Pathe Barry, Mamadou; Pittet, Valérie; von Känel, Roland; Juillerat, Pascal (2023). Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease. European journal of gastroenterology & hepatology, 35(1), pp. 21-30. Wolters Kluwer 10.1097/MEG.0000000000002453

[img]
Preview
Text
Alcohol_and_cannabis_consumption_in_patients_with.82.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (415kB) | Preview

OBJECTIVES OF THE STUDY

There is little guidance regarding the impact of alcohol and cannabis on the clinical course of inflammatory bowel disease. The aim of this study was to assess the prevalence, sociodemographic characteristics and impact of alcohol and cannabis use on the clinical course of the disease.

METHODS

We performed an analysis of prospectively collected data within the Swiss Inflammatory Bowel Disease Cohort Study with yearly follow-ups and substance-specific questionnaires. We analyzed the prevalence of use, the profile of users at risk for addiction and the impact of alcohol and cannabis on the course of the disease.

RESULTS

We collected data of 2828 patients included between 2006 and 2018 and analyzed it according to their completion of specific surveys on alcohol and cannabis use. The prevalence of patient-reported active use was 41.3% for alcohol and 6% for cannabis. Heavy drinkers were over-represented among retired, married smokers receiving mostly aminosalicylates and less immunosuppression. In ulcerative colitis patients, low-to-moderate drinking was associated with less extensive disease. Cannabis users were often students with ileal Crohn's disease.

CONCLUSION

A significant proportion of patients with inflammatory bowel disease consume alcohol or cannabis. Heavy alcohol consumption is most likely in male smokers >50 years, whereas young men with ileal disease rather use cannabis.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Gastroenterology
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine

UniBE Contributor:

Martinho-Grüber, Maude Delphine, Kapoglou, Ioannis, Bravo, Francisco Damian, Sarraj, Riad, Benz, Eileen, Juillerat, Pascal

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1473-5687

Publisher:

Wolters Kluwer

Language:

English

Submitter:

Pubmed Import

Date Deposited:

02 Nov 2022 09:59

Last Modified:

06 Dec 2022 00:15

Publisher DOI:

10.1097/MEG.0000000000002453

PubMed ID:

36317770

BORIS DOI:

10.48350/174413

URI:

https://boris.unibe.ch/id/eprint/174413

Actions (login required)

Edit item Edit item
Provide Feedback